Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Interventional study with minimal risks and constraints, prospective, mono-centric.
Epistemonikos ID: 81b11888abbd7657e6d7a3d75b4f87f4ed8ec8b3
First added on: May 20, 2024